within Pharmacolibrary.Drugs.ATC.J;

model J01AA09
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 1,
    Cl             = 0.5,
    adminDuration  = 600,
    adminMass      = 0.5,
    adminCount     = 1,
    Vd             = 0.0007,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0,
    Tlag           = 0
  );

  annotation(Documentation(
    info ="<html><body><p>Rolitetracycline is a semi-synthetic tetracycline antibiotic formerly used for the treatment of bacterial infections. It was typically administered via injection. Rolitetracycline is no longer widely used or approved in most countries due to the availability of newer antibiotics and concerns about resistance and adverse reactions.</p><h4>Pharmacokinetics</h4><p>Estimated pharmacokinetic parameters in healthy adult population, as explicit published parameters for rolitetracycline could not be found. Values are based on range of tetracycline antibiotics and sparse clinical data available.</p><h4>References</h4><ol><li>Kenneth N Agwuh, Alasdair MacGowan,Pharmacokinetics and pharmacodynamics of the tetracyclines including glycylcyclines.,The Journal of antimicrobial chemotherapy,2006<a href='https://pubmed.ncbi.nlm.nih.gov/16816396/'>https://pubmed.ncbi.nlm.nih.gov/16816396/</a></li><li>L Lashev, D Pashov, I Kanelov,Species specific pharmacokinetics of rolitetracycline.,Zentralblatt fur Veterinarmedizin. Reihe A,1995<a href='https://pubmed.ncbi.nlm.nih.gov/8578898/'>https://pubmed.ncbi.nlm.nih.gov/8578898/</a></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end J01AA09;
